Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
27,844,759
-
Share change
-
+700,990
-
Total reported value
-
$87,170,000
-
Price per share
-
$3.13
-
Number of holders
-
58
-
Value change
-
-$2,008,972
-
Number of buys
-
38
-
Number of sells
-
27
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q2 2019
As of 30 Jun 2019,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,844,759 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Prosight Management, LP, Broadfin Capital, LLC, BlackRock Inc., ARMISTICE CAPITAL, LLC, Hudson Bay Capital Management LP, Opaleye Management Inc., D. E. Shaw & Co., Inc., and 683 Capital Management, LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.